SYN - .8818 Pre-market now at .99/.999. Synthetic Biologics Meets Primary Endpoint In Study Of C. Diff Treatment -- Shares Up More Than 12% http://stockcharts.com/c-sc/sc?s=SYN&p=D&b=5&g=0&i=t88004913083&r=1483624647252 http://stockcharts.com/c-sc/sc?s=SYN&p=W&b=5&g=0&i=t79680813481&r=1483624661415